Accelerate@Babraham
Overview
Accelerate@Babraham is a pre-seed accelerator program based at the Babraham Research Campus that supports early-stage life science ventures through mentorship, access to lab space, and non-dilutive funding.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Creasallis | Sep 2021 | Accelerator | Co-investor |
| ArkVax | Sep 2020 | Accelerator | Co-investor |
| BugBiome | May 2023 | Grant | Co-investor |
| Oppilotech | Jul 2018 | Accelerator | Co-investor |
| Athernal Bio | May 2024 | Accelerator | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Accelerate@Babraham based?
Accelerate@Babraham is headquartered in Cambridge, United Kingdom.
When was Accelerate@Babraham founded?
Accelerate@Babraham was founded in 2018.
How many portfolio companies does Accelerate@Babraham have?
Accelerate@Babraham has 6 portfolio companies in Caplight's dataset.
What are some companies in Accelerate@Babraham's portfolio?
Portfolio companies visible on Caplight include Creasallis, ArkVax, BugBiome, Oppilotech, Athernal Bio.
What was Accelerate@Babraham's most recent investment shown here?
Accelerate@Babraham's most recent investment in this portfolio sample was in Athernal Bio in 2024.
What sectors does Accelerate@Babraham focus on?
Accelerate@Babraham focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure.
What company stages does Accelerate@Babraham focus on?
Stage focus information for Accelerate@Babraham is not publicly available.